| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Alexander J. Denner | 10%+ Owner | $99,127,497 | 04 Mar 2025 | ||
| Pavel Raifeld | Chief Executive Officer, Director | $3,725,793 | 20 Feb 2026 | ||
| Jules Haimovitz | Director | $2,626,612 | 19 May 2025 | ||
| Sarah J. Schlesinger | Director | $2,402,376 | 19 May 2025 | ||
| Mark DiPaolo | Director | $2,402,376 | 19 May 2025 | ||
| George Bickerstaff | Director | $2,202,172 | 25 Apr 2022 | ||
| Kostas D. Odysseas | Director | $1,977,941 | 17 Jun 2024 | ||
| Stephen Basso | Chief Financial Officer | $1,169,804 | 20 Feb 2026 | ||
| Marianne Zhen | Chief Accounting Officer | $1,073,063 | 20 Feb 2026 | ||
| Deborah Birx | Director | $946,693 | 22 May 2023 | ||
| Sapna Srivastava | Director | $711,268 | 17 Jun 2024 | ||
| Matthew Ronsheim | Officer | $653,426 | 20 May 2024 | ||
| Derek A. Small | Director | $647,876 | 19 May 2025 | ||
| GSK plc | 10%+ Owner | 20 May 2021 | |||
| Larry G. Edwards | CEO of La Jolla Pharmaceutical | 22 Aug 2022 | |||
| Margaret Koziel | Chief Medical Officer | 31 Jul 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Stephen Basso | INVA | Common Stock | Tax liability | -2.43% | -1,244 | 50,013 | 20 Feb 2026 | Direct | ||
| Pavel Raifeld | INVA | Common Stock | Tax liability | -1.84% | -2,986 | 159,290 | 20 Feb 2026 | Direct | ||
| Marianne Zhen | INVA | Common Stock | Tax liability | -5.09% | -2,460 | 45,877 | 20 Feb 2026 | Direct | ||
| Stephen Basso | INVA | Common Stock | Tax liability | -0.46% | -237 | 51,257 | 20 Nov 2025 | Direct | ||
| Marianne Zhen | INVA | Common Stock | Tax liability | -2.01% | -992 | 48,337 | 20 Nov 2025 | Direct | ||
| Stephen Basso | INVA | Common Stock | Award | 1.19% | 604 | 51,494 | 15 Nov 2025 | Direct | ||
| Stephen Basso | INVA | Common Stock | Award | 118.6% | 27,609 | 50,890 | 03 Nov 2025 | Direct | ||
| Pavel Raifeld | INVA | Common Stock | Award | 213% | 110,436 | 162,276 | 03 Nov 2025 | Direct | ||
| Stephen Basso | INVA | Common Stock | Tax liability | -1.01% | -237 | 23,281 | 20 Aug 2025 | Direct | ||
| Marianne Zhen | INVA | Common Stock | Tax liability | -1.97% | -991 | 49,329 | 20 Aug 2025 | Direct | ||
| Marianne Zhen | INVA | Common Stock | Tax liability | -1.93% | -992 | 50,320 | 20 May 2025 | Direct | ||
| Stephen Basso | INVA | Common Stock | Tax liability | -1% | -237 | 23,518 | 20 May 2025 | Direct | ||
| Derek A. Small | INVA | Common Stock | Award | 52.1% | 12,077 | 35,249 | 19 May 2025 | Direct | ||
| Derek A. Small | INVA | Non-statutory Stock Option | Award | 10,000 | 10,000 | 19 May 2025 | Direct | |||
| Mark DiPaolo | INVA | Common Stock | Award | 10.2% | 12,077 | 130,706 | 19 May 2025 | Direct | ||
| Mark DiPaolo | INVA | Non-statutory Stock Option | Award | 10,000 | 10,000 | 19 May 2025 | Direct | |||
| Sarah J. Schlesinger | INVA | Common Stock | Award | 10.2% | 12,077 | 130,706 | 19 May 2025 | Direct | ||
| Sarah J. Schlesinger | INVA | Non-statutory Stock Option | Award | 10,000 | 10,000 | 19 May 2025 | Direct | |||
| Jules Haimovitz | INVA | Common Stock | Award | 9.23% | 12,077 | 142,906 | 19 May 2025 | Direct | ||
| Jules Haimovitz | INVA | Non-statutory Stock Option | Award | 10,000 | 10,000 | 19 May 2025 | Direct | |||
| Pavel Raifeld | INVA | Common Stock | Award | 3.72% | 1,860 | 51,840 | 15 May 2025 | Direct | ||
| Stephen Basso | INVA | Common Stock | Award | 6.04% | 1,353 | 23,755 | 15 May 2025 | Direct |